[go: up one dir, main page]

DE602004017512D1 - Neues peptid, verfahren zu dessen herstellung und pharmazeutische zusammensetzung, die das peptid enthält - Google Patents

Neues peptid, verfahren zu dessen herstellung und pharmazeutische zusammensetzung, die das peptid enthält

Info

Publication number
DE602004017512D1
DE602004017512D1 DE602004017512T DE602004017512T DE602004017512D1 DE 602004017512 D1 DE602004017512 D1 DE 602004017512D1 DE 602004017512 T DE602004017512 T DE 602004017512T DE 602004017512 T DE602004017512 T DE 602004017512T DE 602004017512 D1 DE602004017512 D1 DE 602004017512D1
Authority
DE
Germany
Prior art keywords
peptide
preparation
pharmaceutical composition
composition containing
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602004017512T
Other languages
English (en)
Inventor
Henry Aoki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KUBOYAMA BIOKEN CO Ltd
Original Assignee
KUBOYAMA BIOKEN CO Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by KUBOYAMA BIOKEN CO Ltd filed Critical KUBOYAMA BIOKEN CO Ltd
Publication of DE602004017512D1 publication Critical patent/DE602004017512D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rehabilitation Therapy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Tea And Coffee (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE602004017512T 2003-12-29 2004-06-22 Neues peptid, verfahren zu dessen herstellung und pharmazeutische zusammensetzung, die das peptid enthält Expired - Lifetime DE602004017512D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/747,466 US7390874B2 (en) 2003-12-29 2003-12-29 Peptide, method of production thereof, and pharmaceutical composition containing the same
PCT/JP2004/009086 WO2005066200A1 (ja) 2003-12-29 2004-06-22 新規ペプチドとその製造方法およびそのペプチドを含有する医薬組成物

Publications (1)

Publication Number Publication Date
DE602004017512D1 true DE602004017512D1 (de) 2008-12-11

Family

ID=34700745

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004017512T Expired - Lifetime DE602004017512D1 (de) 2003-12-29 2004-06-22 Neues peptid, verfahren zu dessen herstellung und pharmazeutische zusammensetzung, die das peptid enthält

Country Status (9)

Country Link
US (1) US7390874B2 (de)
EP (1) EP1710251B1 (de)
JP (1) JP4516026B2 (de)
KR (1) KR101132077B1 (de)
CN (1) CN1902217B (de)
AT (1) ATE412661T1 (de)
DE (1) DE602004017512D1 (de)
ES (1) ES2317005T3 (de)
WO (1) WO2005066200A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050261197A1 (en) * 2004-05-19 2005-11-24 Henry Aoki Coffee bean extract, method of extraction and composition containing the same
US20070235217A1 (en) * 2006-03-29 2007-10-11 Workman Derek B Devices with microjetted polymer standoffs
CN1879727B (zh) * 2006-05-09 2010-04-21 中国科学院上海药物研究所 新型抗乙肝病毒抑制剂及其应用
US20110009345A1 (en) * 2009-07-08 2011-01-13 Henry Aoki Food ingredient comprising functional peptide
US20110056823A1 (en) * 2009-09-04 2011-03-10 Henry Aoki Methods and apparatus for extracting active ingredients
US10005816B2 (en) * 2014-12-15 2018-06-26 The Folger Coffee Company Peptides and their use in food and beverage
CN109042953B (zh) * 2018-09-12 2024-07-02 中国农业科学院茶叶研究所 一种茶叶炒干机
CN112521442B (zh) * 2020-12-21 2023-04-28 吕梁学院 一种活性肽萃取装置

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4776104A (en) * 1987-04-27 1988-10-11 Kuboyama Nobuyoshi Balanced extraction system
JPH07100008B2 (ja) 1988-06-27 1995-11-01 長谷川香科株式会社 天然苦味物質の製造法
JPH0391456A (ja) 1989-09-01 1991-04-17 Kikkoman Corp 香気成分の濃縮法
US5170697A (en) * 1991-11-12 1992-12-15 Nobuyoshi Kuboyama Extraction apparatus, process and product produced thereby
US5558006A (en) * 1994-08-04 1996-09-24 Kuboyama; Nobuyoshi Health beverage plant extraction apparatus
GB2293776B (en) * 1994-08-04 1996-09-04 Nobuyoshi Kuboyama Health beverage with an extracted ingredient from plant, animal or mineral as major ingredient, and manufacturing method and apparatus therefor
US5572923A (en) * 1995-06-26 1996-11-12 Kuboyama; Nobuyoshi Health beverage that an extracted ingredient from plant, animal or mineral is major ingredient, and manufacturing method and apparatus therefor
US6380370B1 (en) * 1997-08-14 2002-04-30 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to Staphylococcus epidermidis for diagnostics and therapeutics
US5960563A (en) * 1998-01-12 1999-10-05 Big Beans Holding, Ltd. Extraction and drying apparatus
CA2296966A1 (en) 1999-03-04 2000-09-04 Aoki Corporation Extraction apparatus and method
EP1318796A2 (de) 2000-12-06 2003-06-18 Mark B. Lyles Polynukleotid-interkalator-abfänger und inhibitoren

Also Published As

Publication number Publication date
ES2317005T3 (es) 2009-04-16
KR101132077B1 (ko) 2012-04-02
JPWO2005066200A1 (ja) 2007-12-20
US20050143313A1 (en) 2005-06-30
ATE412661T1 (de) 2008-11-15
CN1902217A (zh) 2007-01-24
KR20060128931A (ko) 2006-12-14
US7390874B2 (en) 2008-06-24
EP1710251B1 (de) 2008-10-29
JP4516026B2 (ja) 2010-08-04
EP1710251A4 (de) 2007-10-24
WO2005066200A1 (ja) 2005-07-21
EP1710251A1 (de) 2006-10-11
CN1902217B (zh) 2010-05-05

Similar Documents

Publication Publication Date Title
GEP20084487B (en) Polymer conjugates of cytokines, chemokines, growth factors, polypeptide hormones and antagonists thereof
DE69627035D1 (de) Derivate von aminosäuren, sie enthaltende pharmazeutische zusammensetzungen sowie deren herstellunsgverfahren
ATE361924T1 (de) Dihydropteridinone, verfahren zu deren herstellung und deren verwendung als arzneimittel
DE60222248D1 (de) Aminomethylgruppen enthaltende n-(arylsulfonyl)beta-aminosäure-derivate, verfahren zu deren herstellung sowie deren pharmazeutische zubereitungen
DE69129248D1 (de) Peptide mit Endothelin antagonistischer Aktivität, deren Herstellung und pharmazeutische Zusammensetzungen
ATE252562T1 (de) Pyrazolcarbonsäurederivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
DK1660528T3 (da) Mutein af tåre-lipocalin
DE69104991D1 (de) Mometason-furoate-monohydrat, verfahren zu seiner herstellung und das enthaltende pharmazeutische zusammensetzungen.
DE69733272D1 (de) N-(aryl/heteroarylacetyl)aminosäureester, diese enthaltende pharmazeutische zusammensetzungen und methoden zur inhibierung der beta-amyloidfreisetzung und/oder deren synthese unter verwendung dieser verbindungen
ATE472548T1 (de) Substituierte hexahydro-pyrazino(1,2-a)pyrimidin- 4,7-dionderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DK1511761T3 (da) Fremgangsmåde til fremstilling af cykliske peptider
DE60232158D1 (de) Lipopeptid-stereoisomere, verfahren zu ihrer herstellung und nützliche zwischenprodukte
EP1089968A4 (de) Thyroidhormon-analoga und verfahren zu ihrer herstellung
DE602004017512D1 (de) Neues peptid, verfahren zu dessen herstellung und pharmazeutische zusammensetzung, die das peptid enthält
DE60304599D1 (de) Pyridopyrimidinon-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen
DE69924304D1 (de) N-palmitoylethanolamid-enthaltende pharmazeutische zusammensetzungen und deren verwendung in der veterinärmedizin
BR0315836A (pt) Derivados de [6,7-dihidro-5h-imidazol[1,2-alfa]imadazol-3-sulfonila mino]-propionamida, composição farmacêutica, uso do mesmo, bem como processo para sua preparação
ATE353321T1 (de) Dreiringige verbindungen, verfahren zu ihrer herstellung und zwischenprodukte dieses verfahren,ihre anwendung als arzneimittel und sie enthaltende pharmazeutische zusammensetzungen
ATE203665T1 (de) Stabilisierte pharmazeutische zusammensetzungen und verfahren zu ihrer herstellung
WO2006010084A3 (en) A system for delivering therapeutic agents into living cells and cell nuclei
ATE408619T1 (de) Lh-rh-antagonisten, deren herstellung und verwendung als arzneimittel
DE50301507D1 (de) 17a-FLUORALKYL-11BETA-BENZALDOXIM-STEROIDE, VERFAHREN ZU DEREN HERSTELLUNG, DIESE STEROIDE ENTHALTENDE PHARMAZEUTISCHE PRÄPARATE SOWIE DEREN VERWENDUNG ZUR HERSTELLUNG VON ARZNEIMITTELN
FR2768734B1 (fr) Nouveaux composes tricycliques, leur procede de preparation et les intermediaires de ce procede, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant
HK1042307A1 (zh) 具有刺激胰島素分泌功能的肽
ATE323097T1 (de) Neue 5-thio-ss-d-xylopyranosidderivate, verfahren zu deren herstellung, diese enthaltende pharmazeutische zusammensetzungen und deren therapeutische verwendung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition